The Clinically Active PARP Inhibitor AG014699 Ameliorates Cardiotoxicity but Does Not Enhance the Efficacy of Doxorubicin, despite Improving Tumor Perfusion and Radiation Response in Mice

  1. Lookup NU author(s)
  2. Huw Thomas
  3. Suzanne Kyle
  4. Ivanda Pavlovska
  5. Professor Nicola Curtin
Author(s)Ali M, Kamjoo M, Thomas HD, Kyle S, Pavlovska I, Babur M, Telfer BA, Curtin NJ, Williams KJ
Publication type Article
JournalMolecular Cancer Therapeutics
Year2011
Volume10
Issue12
Pages2320-2329
ISSN (print)1535-7163
ISSN (electronic)1538-8514
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
PublisherAmerican Association for Cancer Research
URLhttp://dx.doi.org/10.1158/1535-7163.MCT-11-0356
DOI10.1158/1535-7163.MCT-11-0356
Actions    Link to this publication
Share